Pediatrics

Reports of high-impact pediatrics studies by medical professionals

Usage of first-line antidepressant medications in early pregnancy associated with selected birth defects

1. Many first-line agents for depression and anxiety – including specific SSRIs, bupropion, and especially venlafaxine – were associated with an increased risk of...

Further evidence that Zika virus disease associated with brain and eye birth defects

1. The prevalence of brain and eye defects was elevated during the 2015-2016 Zika virus outbreak in Colombia compared to the periods immediately before...

Characteristics of COVID-19 in febrile infants 2 months of age and younger

1. In a case series of febrile infants age 60 days or younger admitted to a New York City hospital, no patient had severe...

Metformin associated with retention of cognitive ability and reduced white matter loss in pediatric...

1. Metformin was found to be safe and tolerable in survivors of pediatric brain tumors. 2. Metformin was associated with retention of memory and processing...

Breastfeeding recommended as primary neonatal analgesic in low resource settings

1. Breastfeeding was recommended as a first-line neonatal analgesic for procedures done in non-tertiary care in Kenya. 2. When breastfeeding is unavailable, expressed breastmilk was...

Lung recruitment improves efficacy of surfactant treatment in extremely preterm neonates

1. The intubation-recruitment-surfactant administration-extubation procedure reduced the need for invasive ventilation in extremely preterm neonates compared to those not receiving lung recruitment. 2. There...

Neonatal outcomes in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China

1. Approximately 41.4% of neonates born to COVID-19-positive women in Wuhan, China presented with radiological findings of pneumonia 2. Limited sample size and comparisons limit...

Perinatal transmission of COVID-19 unlikely to occur with appropriate infection control strategies

1. Among neonates born to SARS-CoV-2-positive mothers in three New York Hospitals, none tested positive, or were symptomatic, for the virus at 24 h...

Prophylactic nirsevimab treatment reduces RSV risk in infants

1. Prophylactic nirsevimab lowered the incidence of respiratory syncytial virus (RSV)-associated lower respiratory tract infection compared to the placebo group. 2. Nirsevimab had a favorable...

RSV fusion protein vaccine not effective

1. The respiratory syncytial virus (RSV) fusion (F) vaccine given to pregnant women did not meet efficacy criteria against RSV-associated lower respiratory tract infection...
licensing as small

All-time hits